Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

25.99 -0.07 (-0.29%)
Streaming Delayed Price Updated: 3:39 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 261,934
Open 26.04
Bid (Size) 25.96 (300)
Ask (Size) 26.02 (600)
Prev. Close 26.06
Today's Range 25.69 - 26.54
52wk Range 20.39 - 46.43
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
5 Must-Read Analyst Questions From Amphastar Pharmaceuticals’s Q3 Earnings Call
Amphastar Pharmaceuticals' third quarter results for 2025 came in ahead of Wall Street's revenue and profit expectations, despite essentially flat sales compared to the prior year. The quarter was... 
Via StockStory
Topics Earnings
News headline image
Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-28.5%
-28.5%
1 Month
+9.3%
+9.3%
3 Month
-12.7%
-12.7%
6 Month
+4.8%
+4.8%
1 Year
-41.2%
-41.2%

More News

Read More
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Via ACCESS Newswire
News headline image
Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Why Are Amphastar Pharmaceuticals (AMPH) Shares Soaring Today
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
AMPH Q3 Deep Dive: Pipeline Expansion and Core Product Growth Offset Margin Pressures
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts ↗
Via Benzinga
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Delivers Strong Q3 Numbers
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Target This Week and 2 That Underwhelm
Via StockStory
Topics Economy
News headline image
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
Via ACCESS Newswire
News headline image
2 Reasons AMPH is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Economy Government Stocks
News headline image
Demystifying Amphastar Pharma: Insights From 4 Analyst Reviews ↗
Via Benzinga
News headline image
Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government World Trade
News headline image
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs ↗
Via Benzinga
Topics Government World Trade
News headline image
3 Stocks Under $50 We’re Skeptical Of
Via StockStory
News headline image
3 Value Stocks with Warning Signs
Via StockStory
News headline image
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Value Investor's Opportunity ↗
Via Chartmill
News headline image
3 Low-Volatility Stocks with Open Questions
Via StockStory
News headline image
3 Small-Cap Stocks That Concern Us
Via StockStory
News headline image
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Presents a Compelling Value Investment Case ↗
Via Chartmill

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 25.99
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 11/17/25 03:39 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.25B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.